Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 3987  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page

    Article Cited by others

REVIEW ARTICLE

Biologics : Target - specific treatment of systemic and cutaneous autoimmune diseases

Raychaudhuri Siba P, Raychaudhuri Smriti K

Year : 2009| Volume: 54| Issue : 2 | Page no: 100-109

   This article has been cited by
 
1 Beyond Tumor Necrosis Factor Inhibition: The Expanding Pipeline of Biologic Therapies for Inflammatory Diseases and Their Associated Infectious Sequelae
S. A. Novosad,K. L. Winthrop
Clinical Infectious Diseases. 2014;
[Pubmed]  [Google Scholar] [DOI]
2 Pemphigus vulgaris treated with adalimumab: case study : Pemphigus vulgaris treated with adalimumab
NADěěDA VOJŠčKOVŠ, JORGA FIALOVŠ, DANIELA VAňOUSOVŠ, JANA HERCOGOVŠ
Dermatologic Therapy. 2012; 25(1): 95
[HTML Full text]  [Google Scholar] [DOI]
3 Pemphigus vulgaris treated with adalimumab: Case study
Voj√°ńćkov√°, N. and Fialov√°, J. and VaŇąousov√°, D. and Hercogov√°, J.
Dermatologic Therapy. 2012; 25(1): 95-97
[Pubmed]  [Google Scholar]
4 Comorbidities of psoriatic arthritis - Metabolic syndrome and prevention: A report from the GRAPPA 2010 annual meeting
Raychaudhuri, S.P.
Journal of Rheumatology. 2012; 39(2): 437-440
[Pubmed]  [Google Scholar]
5 A pilot study of the association of tumor necrosis factor alpha polymorphisms with psoriatic arthritis in the Romanian population
Popa, O.M., Bojinca, M., Bojinca, V., Dutescu, M.I., Meirosu, M., Caisan, R.E., Ciofu, C., (...), Popa, L.O.
International Journal of Molecular Sciences. 2011; 12(8): 5052-5059
[Pubmed]  [Google Scholar]
6 Cytokine profiles in the sera of Egyptian patients with oral pemphigus vulgaris
Eid, H., El-Gamal, B.
Brazilian Journal of Oral Sciences. 2011; 10(2): 83-87
[Pubmed]  [Google Scholar]
7 Modulation of toll-like receptors in psoriatic patients during therapy with adalimumab
De Pitŗ, O., Nardis, C., Lupi, F., Luci, C.A., Frezzolini, A., Pallotta, S.
International Journal of Immunopathology and Pharmacology. 2011; 24(1): 185-188
[Pubmed]  [Google Scholar]
8 A Pilot Study of the Association of Tumor Necrosis Factor Alpha Polymorphisms with Psoriatic Arthritis in the Romanian Population
Olivia M. Popa,Mihai Bojinca,Violeta Bojinca,Monica I. Dutescu,Mihaela Meirosu,Ruxandra E. Caisan,Claudia Ciofu,Constantin Bara,Luis O. Popa
International Journal of Molecular Sciences. 2011; 12(12): 5052
[Pubmed]  [Google Scholar] [DOI]
9 Golimumab and certolizumab: The two new anti-tumor necrosis factor kids on the block
Mittal, M. and Raychaudhuri, S.
Indian Journal of Dermatology, Venereology and Leprology. 2010; 76(6): 602-609
[Pubmed]  [Google Scholar]
10 Golimumab and certolizumab: The two new anti-tumor necrosis factor kids on the block
Mittal, M., Raychaudhuri, S.
Indian Journal of Dermatology, Venereology and Leprology. 2010; 76(6): 602-609
[Pubmed]  [Google Scholar]

 

Read this article